ABSTRACT
Ovarian cancer is the fifth most common cancer in women after breast, colorectal, lung and uterine 1 and the second most common gynaecological cancer in the UK after uterine. Each year in the UK about 6700 new cases are diagnosed. Due to its late presentation its prognosis is worse than the other gynaecological cancers and for this reason a high clinical index of suspicion and prompt referral is essential. Approximately 4300 women die from ovarian cancer each year which makes it the leading cause of death in gynaecological cancers. 1 It accounts for 6% of all cancer deaths in women. 1 This is due to the fact that 75% of women present with advanced stage 3C and 4 disease. 2
